Clinical Trial Update: A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis

View source ↗

Summary

A completed serologic study assessing whether neutralizing antibody titers to interferon-beta correlate with biomarker responses in patients with multiple scler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)
• Betaseron (Interferon beta-1b)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED